Posted 17th July 2019 by Jane Williams
Anders Stahlberg works both in the academic setting as Associate Professor at the University of Gothenburg and in the clinical setting at Clinical Genetics & Genomics, Sahlgrenska University Hospital. Together with his colleagues, this means all aspects of circulating cell-free tumour DNA are covered; from basic science and development, understanding why and how liquid biopsies should be undertaken, to clinically focused questions that the patient will hopefully benefit from.
Ahead of the Liquid Biopsies Congress later this year, we spoke to him about his work.
Posted 15th July 2019 by Joshua Sewell
Following the Microbiome R&D & Business Collaboration Forum, we have made the following presentation slides from Karoline Faust, Dirk Hadrich, Lesley Hoyles & Jos Seegers available.
Posted 12th July 2019 by Jane Williams
Numerous skincare brands incorporate lysates in their formulas. However, few brands are able to harness live and active bacteria in addition to the lysates. Neither is an easy task when it comes to formulation however, we can all acknowledge and appreciate the difficulty in working with live probiotics. So, what are the benefits and is this extra challenge worth the effort?
Posted 10th July 2019 by Jane Williams
The PhotoSeed Technology
Enhancing photosynthesis is a critical step to increasing crop yields. This complex 156 step biochemical process has been the subject of many studies in multiple crops. While some step wise gains have been made, the true potential for increasing photosynthesis has not been realized potentially due to the negative feedback mechanisms that exist within plants to regulate this process.
Posted 8th July 2019 by Joshua Sewell
Following the Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress, we have made the following presentation slides from Jonathan Cartoux, Denis Decubber, Hani El-Sabbahy, Julia Leach & Corne Stroop.
Posted 5th July 2019 by Jane Williams
Fecal microbiota transplant (FMT) is probably the microbiome based therapy that has received the most media attention. It seems journalists love to talk about poo.
This has given momentum to research in the field. As the amount of trial data and fear of antibiotic resistance grows, FMT is now a much more common treatment for conditions like clostridioides difficile infection (CDI).
Posted 3rd July 2019 by Jane Williams
2019 may prove to be propitious in terms of meaningful improvements to the regulatory strictures facing agricultural biotech and biologically based products.
In a move that will hopefully lead to positive changes in the regulatory situation facing ag biotech products, on June 11, 2019, President Trump signed an Executive Order directing the heads of the U.S. Department of Agriculture (USDA), Environmental Protection Agency (EPA), and Food and Drug Administration (FDA) to take specific steps to streamline and improve the regulatory processes applicable to the products of agricultural biotechnology.